The company's patented solution consists of an automation unit and single-use kits, supporting cell therapy production at all stages of the life cycle. Limula's platform streamlines the manufacturing process, enabling doctors to provide personalized treatments for better patient outcomes. Its end-to-end automation and integrated process analytics make it possible to produce personalized cancer treatments on demand and at scale, directly at the point of care.